Featured

BioForward Wisconsin is pleased to announce the recipients of the ninth annual Wisconsin Biohealth Awards, recognizing exceptional scientific and business accomplishments within the state’s thriving biohealth industry....

Discovery to Product (D2P) is pleased to share its Annual Impact Report. Learn how D2P makes a difference, providing mentoring, training and funding to UW–Madison innovators and startups and connecting campus and community ecosystems....

In new research published recently in the journal Scientific Reports, Gandara and Drummond-Barbosa describe how chronic exposure to warm temperatures causes infertility in adult male Drosophila....

The University of Wisconsin–Madison has joined a statewide consortium of 15 public and private partners, mobilizing its experience and expertise as a collaborative powerhouse in bioscience and technology to help bolster Wisconsin’s leadership in personalized medicine and biohealth technology....

Cellular therapies, such as Chimeric Antigen Receptor (CAR) T-cell therapy and stem cell therapy, are promising new avenues in cancer treatment and regenerative medicine. Many of these therapies are still in their infancy, requiring further development to increase efficacy and accessibility....

Loading new posts...
No more posts